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Tumor treating fields (TTFields) are alternating electric 
fields, tuned to a frequency between 100 and 300 kHz, 
that have antimitotic properties against rapidly dividing 
cancer cells. When properly applied, these fields disrupt 
macromolecular protein structures thought to possess large 
dipole moments, such as Tubulin and Septin, which are 
critical for proper cytokinesis [1–3]. In past randomized 
clinical trials, TTFields was shown to have comparable 
efficacy against recurrent glioblastoma when compared to 
chemotherapies and, when added to maintenance temo-
zolomide, it had a superior benefit in newly diagnosed 
glioblastoma patients when compared to maintenance 
temozolomide alone [4, 5]. Although the clinical efficacy 
against glioblastoma is apparent, the intracranial 
distribution of the electric fields and to what extent the 
dose of these fields retard tumor growth remain largely 
unknown.
TTFields are applied to the shaved scalp via two pairs 
of orthogonally positioned transducer arrays. Clinical place-
ment of the arrays is determined by the proprietary 
NovoTALTM software that generates an array layout dia-
gram [6]. Each array has nine ceramic disks acting like 
disk sources for the electric fields. However, unlike high- 
energy ionizing radiation that can penetrate intracranial 
structure in a straight beam path, the intensity and direc-
tionality of electric fields are heavily influenced by the 
local dielectric properties of various structures in the head, 
particularly the electric conductivity and the relative per-
mittivity of brain tissue [7]. As the electric conductivity 
and relative permittivity of tissues vary, the absorption 
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Abstract
Tumor Treating Fields (TTFields) therapy is an approved treatment that has 
known clinical efficacy against recurrent and newly diagnosed glioblastoma. 
However, the distribution of the electric fields and the corresponding pattern 
of energy deposition in the brain are poorly understood. To evaluate the physi-
cal parameters that may influence TTFields, postacquisition MP- RAGE, T1 and 
T2 MRI sequences from a responder with a right parietal glioblastoma were 
anatomically segmented and then solved using finite- element method to deter-
mine the distribution of the electric fields and rate of energy deposition at the 
gross tumor volume (GTV) and other intracranial structures. Electric field–volume 
histograms (EVH) and specific absorption rate–volume histograms (SARVH) 
were constructed to numerically evaluate the relative and/or absolute magnitude 
volumetric differences between models. The electric field parameters EAUC, VE150, 
E95%, E50%, and E20%, as well as the SAR parameters SARAUC, VSAR7.5, SAR95%, 
SAR50%, and SAR20%, facilitated comparisons between models derived from vari-
ous conditions. Specifically, TTFields at the GTV were influenced by the dielectric 
characteristics of the adjacent tissues as well as the GTV itself, particularly the 
presence or absence of a necrotic core. The thickness of the cerebrospinal fluid 
on the convexity of the brain and the geometry of the tumor were also relevant 
factors. Finally, the position of the arrays also influenced the electric field dis-
tribution and rate of energy deposition in the GTV. Using EVH and SARVH, 
a personalized approach for TTFields treatment can be developed when various 




1287© 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. 
Physics of Tumor Treating Fields in GlioblastomaE. Lok et al.
and attenuation of TTFields will change and thus the 
distribution of these fields will be distorted as they per-
meate throughout the brain. In addition, there is currently 
no standardized electric conductivity and relative permit-
tivity values for glioblastoma. As each individual tumor 
will vary in size, geometry, location within the brain, 
cellular composition, and presence or absence of necrosis, 
all of which may influence the electric field and energy 
absorption distribution within the glioblastoma. Therefore, 
to properly evaluate how tissue dielectric properties and 
physical characteristics of the various tissues influence the 
applied TTFields in the glioblastoma patient, a computer 
simulated model, currently best solved by the finite- element 
method, is needed. This model takes into account the 
normal brain structures, the gross tumor volume (GTV), 
the presence or absence of a necrotic core within the 
tumor, and local tissue electric conductivity and relative 
permittivity values. Here, we performed detailed finite- 
element modeling of a patient who responded to TTFields 
treatment. We found that there is heterogeneity in the 
electric field intensity and the rate of energy absorbed at 
the GTV depending on the placement of the transducer 
arrays, the presence or absence of a necrotic core within 
the glioblastoma, the thickness of the cerebrospinal fluid 
on the convexity of the brain and tumor geometry. The 
intensity of the electric fields and the specific absorption 
rate (SAR) were also represented graphically by the electric 
field-volume histogram (EVH) and the specific absorption 
rate–volume histogram (SARVH), respectively.
Materials and Methods
Critical neuroanatomical structures such as the scalp, skull, 
dura, cerebrospinal fluid, white matter, gray matter, brain-
stem, cerebellum, orbits, and bilateral ventricles were 
segmented based on the postacquisition MP- RAGE image 
dataset from a responder with a glioblastoma in the right 
parietal brain. The segmentation of these masks was per-
formed using ScanIP (Simpleware LTD., UK) where grey- 
scale thresholding methods were applied to initially 
segmented tissues, followed by manual correction on these 
masks. Additionally, T1 and T2 MRI sequences were also 
imported into ScanIP, and then coregistered with the 
segmented masks for delineation of the GTV and necrotic 
core; the remaining unsegmented tissue was labeled as 
unspecified tissue and given material properties that of 
muscle. Structures such as orbits, brainstem, and cerebel-
lum were segmented and their associated physical properties 
were included mainly for spatial reference in the model. 
The GTV and necrotic core were both manually segmented 
by the treating physician based on the visible enhance-
ment shown on the coregistered postgadolinium T1- and 
T2- weighted image datasets. Transducer arrays were 
manually placed on the surface of the scalp in the model, 
approximating as closely as possible to the standard display 
as shown in the United States Food and Drug 
Administration’s communication on the NovoTTF- 100A 
system [8]. Upon completion of segmentation, a three- 
dimensional finite- element mesh was generated within 
ScanIP. This mesh was then imported into COMSOL 
Multiphysics (COMSOL, Burlington, MA), where material 
properties, boundary conditions, and appropriate physics 
parameters were assigned and applied.
For the purpose of demonstrating the sensitivity of 
varying physical properties, such as electric conductivity 
and relative permittivity, tumor geometry, array disposi-
tion, the introduction or elimination of certain intracranial 
structures, and the expansion or contraction of cerebro-
spinal fluid volume, only isotropic electric conductivity 
values were used in order to simplify the modeling process. 
Data postprocessing of the solved models was performed 
using Microsoft Excel, including generation of volume 
histograms EVH and SARVH. Area under the curve was 
computed using Simpson’s Rule integration in MATLAB 
2016 for electric fields (EAUC) and SAR (SARAUC). The 
EVH was used in the comparison of electric field strength 
between different models and was referenced to (1) the 
percentage volume of a particular structure receiving at 
least 150 V/m (VE150), (2) the magnitude of electric field 
strength encompassing 95% of a particular structure’s 
volume (E95%), (3) the magnitude of electric field strength 
encompassing 50% of a particular structure’s volume (E50%), 
and (4) the magnitude of electric field strength encom-
passing 20% of a particular structure’s volume (E20%). 
Similarly, the comparison of the rate of energy absorbed 
in different SARVH models was referenced to (1) the 
percentage volume of a particular structure receiving at 
least 7.5 W/kg (VSAR7.5), (2) the magnitude of SAR encom-
passing 95% of a particular structure’s volume (SAR95%), 
(3) the magnitude of SAR encompassing 50% of a par-
ticular structure’s volume (SAR50%), and (4) the magnitude 
of SAR encompassing 20% of a particular structure’s 
volume (SAR20%).
Results
Electric field distribution of a responder 
treated with TTFields
A retrospective analysis of one glioblastoma patient, who 
responded to TTFields treatment, was performed by 
modeling the intracranial electric field distribution using 
finite- element analysis. The responder had a glioblastoma 
in the right parietal lobe extending toward the bilateral 
ventricles with roughly 1.5 cm between the GTV and 
the lateral border of the right lateral ventricle. As expected, 
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the highest electric field intensity was seen within the 
sulci on the surface of the brain and it is associated 
with a high- to- low gradient from the surface to the 
deeper regions (Fig. 1). In particular, the lowest intensity 
was seen in the inferior portion of the frontal (Fig. 1C 
and I) and the temporal (Figs. 1B and H) lobes. 
Furthermore, the body of the corpus callosum had high 
electric field intensity, particularly in the regions between 
(Fig. 1D) and above the lateral ventricles (Fig. 1E and 
F). This is likely due to the relatively higher electric 
conductivity of the cerebrospinal fluid located next to 
either side of the lesser conductive white matter, which 
probably created a higher capacitive reactance similar 
to a capacitor, helped to retain a higher electric field 
intensity within the white matter. Lastly, the medial por-
tion of GTV in the right parietal lobe also possessed a 
higher electric field intensity. This could be a result of 
a relatively higher electric conductivity of the necrotic 
core within the GTV on one side and the cerebrospinal 
fluid within the right lateral ventricle on the other side, 
both of which also likely contributed to a higher reac-
tive capacitance within the right parietal tissue.
To investigate the strength of electric field and the rate 
of energy deposited into the GTV and various intracranial 
structures, EVH and SARVH were generated for the com-
parison between models that use the primary position 
for transducer array placement as outlined in Figure 3E 
and incorporate the isotropic electric conductivity and 
relative permittivity values listed in Table 1 [9, 10]. As 
expected, the highest EAUC was found at the scalp and 
skull, whereas the lowest was located at the orbits, bilateral 
ventricles, and brainstem (Fig. 2A and C). In the GTV, 
95% of the volume had an electric field intensity of 
>50 V/m, whereas 50% had >80 V/m and 20% has 
>150 V/m (Fig. 2A). Because at least 20% of the GTV 
volume had a minimum of 150 V/m of electric field 
Figure 1. Distribution of TTFields within a patient brain. The electric field intensity is higher in the supratentorial than the infratentorial brain. Within 
the supratentorial brain, various parts of the sulci, the body of the corpus callosum, and the medial surface of the GTV appear to have the highest 
electric field intensity. Axial images from inferior to superior slices are shown in A, D and G. Coronal images from anterior to posterior slices are shown 
in B, E and H. Sagittal images from right to left slices are shown in C, F and I. TTFields, Tumor Treating Fields; GTV gross tumor volume.
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coverage (Table 2), the VE150 volume and E50% magnitude 
were used as means of comparing different modeling 
outcomes in subsequent analyses. Similarly, the highest 
SARAUC was found at the skull, GTV, and the layer of 
cerebrospinal fluid between cortex and dura, whereas the 
lowest were located in the orbits, cerebellum, and brain-
stem (Fig. 2B and D). Because at least 15% of the GTV 
volume had a SAR of at least 7.5 W/kg (Table 2), the 
VSAR7.5 volume and SAR50% magnitude were used as means 
of comparing different modeling outcomes in subsequent 
analyses.
Disposition analysis of transducer array 
placement
As the placement of transducer arrays can be shifted dur-
ing each array exchange on treatment, we investigated 
whether or not the disposition of the arrays can alter 
electric field coverage and rate of energy deposition in 
the GTV. The effects of shifting array positions at dif-
ferent locations on the scalp were modeled according to 
an aggregate 2- cm deviation from the primary position; 
each of the nine disks in each array were manually drawn 
to scale and placed in full contact with the surface of 
the scalp in the configuration of the primary position as 
shown in Figure 3E. The lateral arrays were then shifted 
in clockwise or counterclockwise configurations, whereas 
the anterior–posterior arrays were shifted in the forward 
or backward positions, resulting in eight additional con-
figurations (Fig. 3, except for Fig. 3E [primary position]). 
The posterior array in all cases was not moved inferiorly 
due to the fact that the patient’s image dataset was trun-
cated at the occiput, and thus had insufficient occipital 
anatomy to shift the posterior array inferiorly. Still, there 
was high variance in electric field coverage of the GTV 
between 100 and 150 V/m, ranging from only 20% volume 
having 100 V/m with clockwise rotation of the lateral 
arrays and no displacement of the anterior–posterior arrays 
(Fig. 4A, red curve and Table 3) to >40% volume having 
at least 150 V/m when the lateral arrays were rotated in 
a counterclockwise fashion and the anterior array was 
moved backward (Fig. 4A, green curve). However, the 
variability in SAR, as represented by the magnitude of 
SAR50%, was low and it ranged between 3 and 6 W/kg 
(Fig. 4B). For the necrotic core of the tumor, there was 
also a similar but smaller variance in the electric field 
coverage (Fig. 4C) and its corresponding SAR magnitude 
(Fig. 4D).
Sensitivity analysis of the conductivity of 
the GTV and the necrotic core
The strength of the electric field penetrating the GTV most 
likely depends on its dielectric properties, specifically the 
electrical conductivity and relative permittivity. Our previ-
ous modeling found that the electric field intensity at the 
GTV is more sensitive to changes in its electric conductivity 
than its relative permittivity characteristics [7]. However, 
glioblastoma frequently has a necrotic component that 
contains liquefied cellular products or exudates from adja-
cent highly permeable vasculature. The fluid component 
of this necrotic core can potentially influence the electric 
field strength within the GTV. To investigate the relation-
ship between the field coverage at both GTV and necrotic 
core, the electric conductivity of the GTV was altered from 
100 to 0.001 S/m, whereas the electric conductivity of the 
necrotic core was kept constant. The mean electric field 
strength within the necrotic core rose 600% from 5 to 
Table 1. Physical parameters required as inputs for computer modeling.
Tissue structure Volume (cc) Electric conductivity σ (S/m) Relative permittivity εr
Gross tumor volume (GTV) 5.813874 2.50E- 01 1.00E+04
Necrotic core 2.421458 1.00E+02 1.00E+00
Scalp 524.5453 1.05E- 03 1.10E+03
Skull 463.5451 2.11E- 02 2.04E+02
Dura 216.8171 5.02E- 01 2.90E+02
Cerebrospinal fluid 238.8805 2.00E+00 1.09E+02
White matter 593.1396 8.68E- 02 1.29E+03
Gray matter 261.5665 1.41E- 01 2.01E+03
Bilateral ventricle 51.38429 2.00E+00 1.09E+02
Brainstem 28.7721 1.61E- 01 2.30E+03
Orbits 12.89734 1.50E+00 9.66E+01
Cerebellum 44.55224 1.61E- 01 2.30E+03
Unspecified tissue/muscle 133.3064 3.84E- 01 6.38E+03
Electrodes N/A 1.00E- 05 1.10E+04
Titanium wires N/A 1.28E+06 5.00E+01
The volume, electric conductivity and relative permittivity values for GTV, necrotic core, scalp, skull, dura, cerebrospinal fluid, white matter, gray 
 matter, bilateral ventricles, brainstem, orbits, cerebellum, unspecified tissue/muscle, electrodes, and titanium wires that were used in the analysis.
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30 V/m when the electric conductivity of the GTV decreased 
from 100 to 1 S/m, but further increase was markedly 
attenuated when the electric conductivity was lowered from 
1 to 0.001 S/m (Fig. 5A). Similarly, the mean SAR increased 
from 0 to 1.8 W/kg when the electric conductivity of the 
GTV decreased from 100 to 1 S/m, but further increase 
was negligible when the electric conductivity was lowered 
from 1 to 0.001 S/m (Fig. 5C). In contrast, when the 
electric conductivity of the necrotic core was varied from 
100 to 1 S/m, there was negligible change in the mean 
electric field strength in the GTV; however, there was up 
to a 10% increase in mean electric field strength of the 
GTV when the electric conductivity of the necrotic core 
was lowered from 1 to 0.001 S/m (Fig. 5B). But the change 
in mean SAR of the GTV was insignificant when the electric 
conductivity of the necrotic core was varied from 100 to 
0.001 S/m (Fig. 5D).
To further investigate the electric field coverage of GTV 
as influenced by the conductivity of the necrotic core, 
both EVH and SARVH were constructed as the GTV was 
Figure 2. Volume histograms EVH and SARVH. The EVH (A), SARVH (B), electric field map (C), and SAR map (D) were generated using the transducer 
array placement as outlined in Figure 3E. The highest EAUC was found at the scalp and skull, whereas the lowest was detected at the orbits, bilateral 
ventricles, and brainstem. The highest SARAUC was found at the skull, GTV, and the layer of cerebrospinal fluid between cortex and dura, whereas the 
lowest was found in the orbits, cerebellum, and the orbits. EVH, electric field–volume histogram; SARVH, specific absorption rate–volume histogram; 
SAR, specific absorption rate.
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modeled with or without the necrotic core. When highly 
conductive fluid in the necrotic core was replaced with 
electric conductivity and relative permittivity of white 
matter, the VE150 of the GTV shifted from 20% to 30% 
(Figs 6A and B) and the corresponding VSAR7.5 increased 
from 13% to 15% (Figs 6C and D), indicating that electric 
field and SAR coverage of the GTV increased as the highly 
conductive fluid within the necrotic core is replaced with 
an electrically lower conductive material property. Because 
the dielectric properties of GTV and necrotic core prob-
ably vary among individual patients, the findings here 
indicate that acquiring individualized electric conductivity 
and permittivity values for these structures may have 
clinical relevance when modeling TTFields in glioblastoma 
patients.
The influence of cerebrospinal fluid on GTV
As cerebrospinal fluid is a highly conductive medium 
compared with ordinary brain tissue and it is in close 
proximity to the GTV, especially in our patient, we sought 
to investigate whether the cerebrospinal fluid along the 
surface of the brain and inside the ventricles could influ-
ence the electric field and SAR coverage of the GTV. 
First, 0.5 mm of cerebrospinal fluid was added on the 
surface or 0.5 mm to 1.0 mm of cerebrospinal fluid was 
subtracted from the surface of the original brain, cor-
responding to a respective volume of 275 cc, 196 cc and 
179 cc compared to the initial volume of 240 cc. Indeed, 
EAUC, VE150, and E50% of the GTV all increased progres-
sively when the cerebrospinal fluid space was narrowed 
progressively from +0.5 mm to −1.0 mm on the 
convexities of the brain. Specifically, EAUC increased from 
94.0 V/m at +0.5 mm to 115.1 V/m at −0.5 mm, and 
to 122.1 V/m at −1.0 mm (Fig. 7C). Similarly, the rate 
of energy deposited in the GTV increased progressively, 
as represented by SARAUC, VSAR7.5, and SAR50%, when the 
cerebrospinal fluid space was narrowed from +0.5 to 
−1.0 mm on the convexities of the brain. In particular, 
SARAUC increased from 5.1 W/kg at +0.5 mm, to 6.8 W/
kg at −0.5 mm, and to 7.4 W/kg at −1.0 mm (Fig. 7C). 
Therefore, increased cerebrospinal fluid space at the con-
vexity shunts electric field and energy away from the brain, 
whereas decreased cerebrospinal fluid space allows a higher 
intensity of electric field and SAR to penetrate the brain.
The influence of the material properties of 
tumor, necrotic core, and bilateral ventricles 
on EVH and SARVH
By replacing the material properties of the segmented 
volume representing the original tumor (GTV + necrotic 
core) with that of white matter, the electric field strength 
in terms of EAUC, VE150, E95%, E50%, and E20% were all 
remarkably higher compared with the model containing 
the original tumor (Fig. 7C); proportionally the SAR 
was also increased dramatically. The EAUC for the original 
tumor was 104 V/m in comparison to 153.9 V/m after 
the change, which is an increase of about 48%. The 
SARAUC also increased by 120%, from 5.9 to 13.0 W/
kg. Similarly, but not as dramatically, replacing the mate-
rial properties of the segmented necrotic core with that 
of white matter increased the electric field strength and 
SAR within the GTV. Specifically, the EAUC of the replaced 
Table 2. The values for electric field and rate of energy deposition parameters at the GTV and other structures in the head as shown in EVH and 
SARVH from Figure 2.
Tissue structure EAUC VE150 (%) E95% E50% E20% SARAUC VSAR7.5 (%) SAR95% SAR50% SAR20%
Bilateral ventricle 14.7 0.0 5.7 9.8 25.2 4.0 13.1 0.7 2.6 5.3
Brainstem 35.7 0.0 23.6 36.3 44.0 1.2 0.0 1.2 2.1 2.6
Cerebellum 50.4 0.1 32.0 49.0 62.6 1.0 0.0 0.8 2 2.5
Cerebrospinal fluid 67.3 12.3 21.0 53.5 90.2 19.0 58.6 2.2 9.2 30
Dura 108.3 35.7 25.4 86.2 169.8 8.2 32.3 1.3 4.9 17.1
Gray matter 108.1 31.0 37.7 87.2 164.7 2.5 5.6 0.8 2.6 4.3
Gross tumor volume (GTV) 104.0 21.7 57.0 89.7 153.5 5.9 13.9 2.1 4.1 6.2
Necrotic core 54.1 0.0 38.8 53.8 65.2 3.5 5.6 2.3 4.1 5.8
Orbits 5.7 0.0 4.2 6.2 7.8 0.0 0.0 0.5 0.8 0.9
Scalp 596.0 71.2 24.8 >1000 >1000 8.7 21.0 0.1 0.9 8.3
Skull 537.8 67.1 24.6 437.2 >1000 31.8 38.1 0.6 2.5 42.8
White matter 126.9 45.3 48.7 137.0 169.8 2.2 2.4 0.9 2.7 4.3
GTV, gross tumor volume; EVH, electric field–volume histogram; SARVH, specific absorption rate–volume histogram; EAUC, electric field area under the 
curve; VE150, volume covered with electric field intensity of 150 volts per meter; E95%, the electric field intensity encompassing 95% of volume; E50%, 
the electric field intensity encompassing 50% of volume; E20%, the electric field intensity encompassing 50% of volume; SAR, specific absorption rate; 
SARAUC, SAR area under the curve; VSAR7.5, volume covered with specific absorption rate of 7.5 watts per kilogram; SAR95%, the magnitude of specific 
absorption rate encompassing 95% of volume; SAR50%, the magnitude of specific absorption rate encompassing 50% of volume; SAR20%, the mag-
nitude of specific absorption rate encompassing 20% of volume.
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necrotic core and the original tumor was 111.8 and 
104.0 V/m, respectively. In addition, the SARAUC of the 
replaced necrotic core and the original tumor was 6.1 
and 5.9 W/kg, respectively. Interestingly, when the mate-
rial properties of the bilateral ventricle, which was con-
sidered a highly conductive medium, were replaced with 
the properties of gray matter, neither the electric field 
strength nor SAR changed significantly. This is possibly 
due to the bulk of the incident electric fields, which 
permeate first through cerebrospinal fluid at the convex-
ity of the brain, has already deposited most of the energy 
at the convexity interface as the cerebrospinal fluid in 
this region is highly conductive compared with adjacent 
tissues. In contrast, the intensity of the source fields 
was not easily altered in regions deep within the center 
of the brain where the bilateral ventricles are located.
The influence of tumor geometry on EVH 
and SARVH
The influence of tumor geometry on the electric field 
and rate of energy deposition was also investigated. The 
initial GTV was kept intact as segmented in the patient’s 
model, and was used to compare with GTVs of other 
standard geometric solids, while keeping the centroid of 
each GTV at the same location. All other parameters such 
as array position and electric conductivity of tissue remained 
the same (Fig. 3E and Table 1). Standard geometric solids, 
including cube, cylinder, sphere, icosahedron, and cone, 
were used to represent the shape of the tumor for study-
ing changes in electric field distribution and energy depo-
sition in the GTV (Fig. 8). To simplify the comparisons, 
the necrotic core properties across all models, including 
the original brain model, were set equal to the GTV; 
thus, the GTV studied in this section is essentially GTV 
and necrotic core combined into one entity. In addition, 
we were interested to determine how the electric fields 
are distributed depending on the orientation of the conical 
solid. Therefore, the conical solid was rotated about the 
geometric centroid of the original patient’s GTV, with 
the tip of the solid pointing in six different directions 
according to the patient’s anterior, posterior, left, right, 
superior, or inferior head positions.
Compared to the original tumor geometry, symmetric, 
less angulated geometries had a tendency to associate 
with a lower basal level of electric fields, as shown by 
lower values in EAUC and E20%, and diminished energy 
absorption, as shown by SARAUC and SAR20% (Fig. 9). 
Figure 3. Array displacement for disposition analysis. The original array placement position was determined by the NovoTALTM software that 
generated an array placement diagram (E). The disks in each array were then rotated in aggregate by 2- cm deviation from the primary position in a 
clockwise fashion (A, D, and G) and counterclockwise fashion (C, F, and I). In addition, the posterior arrays were moved in aggregate by 2- cm 
deviation forward (A, B, and C) and backward (G, H, and I).
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In particular, the cylindrical and spherical GTVs had 
lower EAUC and E20%, as well as SARAUC and SAR20%, than 
that for the cube and icosahedron, and these changes 
are likely due to the fact that the latter ones had more 
angulated corners. For lesser symmetric geometric shapes, 
such as a cone, the orientation in three- dimensional 
space of the brain was important. The EAUC and E20%, 
as well as SARAUC and SAR20%, had the lowest values 
when the cone was pointing superiorly but highest when 
pointing anteriorly (Figs. 8B and  9C). The highest values 
of EAUC 122.0 V/m and E20% 163.9 V/m, as well as SARAUC 
6.5 W/kg and SAR20% 7.8 W/kg, were found when the 
conical GTV was pointing anteriorly, with the flat surface 
facing orthogonal to the lateral ventricle.
Discussion
As it is being used to treat glioblastoma, TTFields at 
200 kHz permeate the patient brain according to the laws 
of physics, including Gauss’ law, Coulomb’s law, and the 
principles of continuity and capacitance. Our modeling 
of these fields using the finite- element method reveals 
that the intensity of TTFields is highest at the sulci, genu 
of the corpus callosum, and at the medial surface of the 
Figure 4. EVH and SARVH generated from array displacement analysis. Electric field coverage of the GTV was highly variable between 100 and 
150 V/m, ranging from only 20% volume having 100 V/m with clockwise rotation of the lateral arrays and no displacement of the anterior–posterior 
arrays (red curve), to >40% volume having at least 150 V/m when the lateral arrays were rotated in a counterclockwise fashion and the anterior array 
was moved backward (green curve) (A). However, the variability in the magnitude of SAR encompassing 50% of the GTV, as represented by SAR50%, 
was low and it ranged between 3 and 6 W/kg (B). For the necrotic core of the tumor, the electric field (C) and SAR magnitude (D) variability at the 
GTV were also smaller. Each color- coded curve corresponds to specific array placement position as shown in Figure 3A: CW+Forward, Figure 3B: 
Forward Only, Figure 3C: CCW+Forward, Figure 3D: CW+No AP PA Difference, Figure 3E: Primary Position, Figure 3F: CCW+No AP PA Difference, 
Figure 3G: CW+Backward, Figure 3H: AP Only Backward, and Figure 3I: CCW+AP Backward. AP, anteroposterior; PA, posteroanterior; CW, clockwise; 
CCW, counterclockwise; EVH, electric field–volume histogram; SARVH, specific absorption rate–volume histogram; GTV, gross tumor volume; V/m, 
volt per meter; W/kg, watt per kilogram; SAR, specific absorption rate; SAR50%, the magnitude of SAR encompassing 50% of volume.
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GTV facing the lateral ventricle. To better assess quan-
titatively the electric field distribution and rate of energy 
deposition within the brain, volume histograms were 
constructed for the electric fields and SAR. To our knowl-
edge, this is the first comprehensive usage of both EVH 
and SARVH to quantify and compare, respectively, TTFields 
distribution and rate of energy deposition within the 
patient brain and tumor in various models. Both EVH 
and SARVH can also facilitate the quantitative comparison 
of intracranial TTFields between patients, using prespeci-
fied values at the GTV and other segmented structures, 
such as EAUC, VE150, E95%, E50%, and E20% for TTFields dis-
tribution as well as SARAUC, VSAR7.5, SAR95%, SAR50%, and 
SAR20% for rate of energy deposition. EAUC represents the 
aggregate electric fields as represented by the area under 
the curve within any segmented structures and VE150 is 
the volume of distribution for the electric field intensity 
at least 150 V/m on the histogram. Similarly, SARAUC also 
represents the aggregate rate of energy deposited as rep-
resented by the area under the curve within any segmented 
structures and VSAR7.5 is the volume of distribution for 
SAR at 7.5 W/kg on the histogram. In addition, E95%, 
E50%, and E20% are data points on the EVH curve that 
represent the electric field intensity that covers 95%, 50%, 
and 20% of the GTV, whereas SAR95%, SAR50%, and SAR20% 
are data points on the SARVH that represent the rate of 
energy deposited in 95%, 50%, and 20% of the GTV. 
Collectively, these parameters quantitatively represent the 
intrinsic characteristics of EVH and SARVH and therefore 
allow the comparison of TTFields among different patients.
Our TTFields modeling is based on MP- RAGE, T1, 
and T2 MRI sequences obtained from a patient with 
glioblastoma in the right parietal brain. Using patient- 
based MRI for finite- element modeling has several distinct 
advantages compared to modeling based on atlas- based 
human head and/or generalized tumor model [10, 11]. 
First, there are intrinsic factors that are unique to the 
individual human head that may influence the electric 
field and rate of energy deposition in the GTV. A prime 
example is the volume of the cerebrospinal fluid within 
the subarachnoid space at the convexity. Because cerebro-
spinal fluid is a good electric conductor, a thicker layer 
tends to shunt TTFields away from the brain while a 
thinner layer allows more fields to penetrate the brain 
and eventually to the GTV. Indeed, as brain atrophy occurs 
in the general population spanning the entire age con-
tinuum in adulthood, there is a simultaneous increase in 
cerebrospinal fluid space from age 18 to 80 [12]. 
Furthermore, the rate of atrophy is quicker for men than 
woman, particularly in the left hemisphere, suggesting 
neuroanatomical differences between genders [12]. Second, 
the presence or absence of the necrosis within the 
Table 3. Disposition analysis of transducer array placement on EVH and SARVH.
Structure Array position EVH SARVH
VE150 (%) E95% E50% E20% VSAR7.5 (%) SAR95% SAR50% SAR20%
GTV AP Backward Only 26.71 59.2 92.5 159.2 15.20 2.2 4.4 6.7
CCW + Forward 16.70 52.2 83.5 139.5 7.10 1.8 3.7 5.7
CCW AP backward 42.84 65.7 107.0 164.5 27.49 2.5 5.2 8.2
CCW No AP PA difference 18.44 53.1 85.0 146.0 7.53 1.8 3.8 5.9
CW backward 36.35 58.3 98.2 164.4 20.92 2.2 5.0 7.7
CW forward 29.34 55.6 93.5 161.1 8.09 1.5 3.4 5.2
CW No AP PA Difference 14.70 48.3 79.4 104.0 8.09 1.5 3.4 5.2
Forward only 25.56 59.4 92.5 158.4 15.78 2.2 4.4 6.6
No Shift 21.66 57.0 89.7 153.5 13.88 2.1 4.1 6.2
Necrotic 
Core
AP backward only 0.04 39.4 54.7 65.8 0.26 1.7 3.0 4.1
CCW + forward 0.01 33.4 48.1 56.9 0.10 1.2 2.4 3.3
CCW AP Backward 0.11 42.6 60.2 72.7 1.41 2.1 3.5 4.8
CCW No AP PA Difference 0.01 33.9 48.9 57.8 0.12 1.3 2.6 3.4
CW backward 0.12 36.7 53.3 65.6 0.60 1.5 2.9 4.1
CW forward 0.10 36.7 52.8 64.9 0.58 1.5 2.9 4.0
CW No AP PA difference 0.02 32.2 45.3 54.9 0.10 1.0 2.3 3.0
Forward only 0.05 40.4 56.5 67.1 0.33 1.8 3.1 4.3
No shift 0.05 38.8 53.8 65.2 0.35 1.6 3.0 4.0
GTV, gross tumor volume; EVH, electric field–volume histogram; SARVH, specific absorption rate–volume histogram; VE150, volume covered with 
electric field intensity of 150 volts per meter; E95%, the electric field intensity encompassing 95% of volume; E50%, the electric field intensity encom-
passing 50% of volume; E20%, the electric field intensity encompassing 50% of volume; SAR, specific absorption rate; VSAR7.5, volume covered with 
specific absorption rate of 7.5 watts per kilogram; SAR95%, the magnitude of specific absorption rate encompassing 95% of volume; SAR50%, the 
magnitude of specific absorption rate encompassing 50% of volume; SAR20%, the magnitude of specific absorption rate encompassing 20% of vol-
ume. AP, anteroposterior; PA, posteroanterior; CW, clockwise; CCW, counterclockwise.
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glioblastoma also can influence the distribution of TTFields 
at the GTV [12]. The necrotic core is primarily consisted 
of a collection of thick fluid from broken- down cellular 
debris containing various proteins and metabolites [13, 
14]. Because this fluid is ionic and highly conductive, it 
may direct electric fields toward the more cellular portion 
of the GTV. Indeed, our modeling has shown that the 
necrotic core can influence both the electric field strength 
and SAR within the adjacent GTV as the electric con-
ductivity of GTV varied from 100 to 1 S/m. Lastly, glio-
blastoma is an infiltrative tumor [15] and the accumulation 
of the tumor cells in the adjacent gyri and sulci may 
change the geometry of the tumor. Our geometric analysis 
has shown that electric field and SAR values grossly increase 
as the tumor geometry becomes more angulated, as seen 
in the cube and icosahedron models compared to spheri-
cal and cylindrical models. This is likely due to the fun-
damental basis of electric force and surface charge 
distribution, where charges bunched up at sharp corners 
experience a very high internal electric force exerted upon 
adjacent charges, thereby creating a higher electric field. 
Likewise, smoother surfaces enable electric charges to 
distribute more uniformly, generating a lower electric field. 
An extreme form of tumor geometric asymmetry is rep-
resented by a cone and modeling revealed that the ori-
entation of this structure is important, resulting in highest 
electric field intensity and SAR in this particular patient 
model  when the vertex is pointing anteriorly and the 
flat base is facing orthogonally to the lateral ventricle. 
Taken together, atlas- based modeling may not accurately 
Figure 5. Sensitivity analysis of electric conductivity of GTV and necrotic core. When the electric conductivity of the necrotic core was held constant, 
the mean electric field strength within the necrotic core rose 600% from 5 to 30 V/m when the conductivity of the GTV decreased from 100 to 1 S/m, 
but further increase was markedly attenuated when the conductivity was lowered from 1 to 0.001 S/m (A). The mean SAR increased from 0 to 1.8 W/
kg when the conductivity of the GTV was decreased from 100 to 1 S/m, but further increase was negligible when the conductivity was lowered from 
1 to 0.001 S/m (C). When the electric conductivity of the GTV was held constant and the electric conductivity of the necrotic core was varied from 
100 to 1 S/m, there was negligible change in the mean electric field strength in the GTV; but there was up to a 10% increase in mean electric field 
strength of the GTV when the electric conductivity of the necrotic core was lowered from 1 to 0.001 S/m (B). However, the change in mean SAR of 
the GTV was insignificant when the necrotic core conductivity was varied from 100 to 0.001 S/m (D). GTV, gross tumor volume; V/m, volt per meter; 
S/m, Siemens per meter; W/kg, watt per kilogram; SAR, specific absorption rate.
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Figure 6. Sensitivity analysis for electric field strength and rate of energy deposition with or without the necrotic core. EVH (A) and SARVH (C) were 
modeled with the necrotic core, which consisted of highly conductive fluid. When the electric properties of the necrotic core were replaced with 
poorly conductive tissue, such as white matter, the electric field coverage and rate of energy deposition were increased as shown in the EVH (B) and 
SARVH (D), respectively. The electric field diagrams showed differences in the electric field coverage at the GTV with (E) and without (F) the necrotic 
core. EVH, electric field–volume histogram; SARVH, specific absorption rate–volume histogram.
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incorporate patient- related differences in brain volume, 
CSF space and physical characteristics of the tumor, all 
of which influence TTFields distribution in the brains of 
glioblastoma patients.
Transducer array positioning also influences TTFields 
distribution within the brain. In accordance to the data 
present by Wenger et al. [6], we also noted changes in 
TTFields at the GTV depending on array positioning, with 
Figure 7. Influence of cerebrospinal fluid on the electric field strength and rate of energy deposition at the GTV and necrotic core. The layer of 
cerebrospinal fluid was altered by −1.0 mm, −0.5 mm, and +0.5 mm at the convexity of the brain and the respective EVH (A) and SARVH (B) at the 
GTV were generated. The electric field parameters EAUC, VE150, and E50%, as well as parameters for the rate of energy deposition SARAUC, VSAR7.5, and 
SAR50%, all increased progressively when the cerebrospinal fluid space was narrowed progressively from +0.5 mm to −0.5 mm, and then to −1.0 mm 
on the convexity of the brain. GTV, gross tumor volume; EVH, electric field–volume histogram; SARVH, specific absorption rate–volume histogram; 
EAUC, electric field area under the curve; VE150, volume covered with electric field intensity of 150 volts per meter; and E50%, the electric field intensity 
encompassing 50% of volume; SAR, specific absorption rate; SARAUC, SAR area under the curve; VSAR7.5, volume covered with specific absorption rate 
of 7.5 watts per kilogram; SAR50%, the magnitude of specific absorption rate encompassing 50% of volume.
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significant variability in the electric field strength of GTV 
between 100 and 150 V/m, ranging from only 20% volume 
having 100 V/m with clockwise rotation of the lateral arrays 
and no displacement of the anterior–posterior arrays to 
>40% volume having at least 150 V/m when the lateral 
arrays are rotated in a counterclockwise fashion and the 
anterior array is moved backward. SAR variability in the 
rate of energy deposition was less dramatic, as the mag-
nitude of SAR50% changes between 3 and 6 W/kg. These 
results suggest that array positioning is important to maxi-
mize TTFields distribution at the GTV and to determine 
if the maximal electric field distribution correlates with 
survival in the patient population treated with TTFields.
Our results have limitations. First, our modeling only 
used isotropic values but there are local fields generated 
by the electrical activities of neurons and the flow of cer-
ebrospinal fluid that influence regional electric conductivity 
[16, 17]. Therefore, anisotropic mapping may delineate a 
more accurate distribution of TTFields. However, for com-
paring various structural components that may influence 
TTFields, isotropic modeling still allows a relatively accurate 
comparison among different dielectric- , geometric- , and 
tumor- related parameters. Second, the GTV is delineated 
by the leakage of gadolinium across permeable tumor 
vasculature. But this vascular permeability can be increased 
or decreased by radiation and drugs, as in, respectively, 
Figure 8. Geometric analysis of GTV. The glioblastoma was represented by standard and relatively symmetric geometric solids, including cube, 
cylinder, sphere, and icosahedron, for studying changes in electric fields distribution and energy deposition in the GTV (A). The conical shape was also 
chosen because it is extremely asymmetrical. Its position in the brain, as represented by the anterior, posterior, left lateral, right lateral, inferior, and 
superior orientations, was also used for studying changes in electric fields distribution and energy deposition in the GTV (B). GTV, gross tumor volume; 
EVH, electric field–volume histogram; SARVH, specific absorption rate–volume histogram.
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pseudoprogression after concurrent radiation and temo-
zolomide treatment for newly diagnosed glioblastoma or 
pseudoresponse after the administration of an antiangio-
genic agent like bevacizumab [18]. Therefore, the GTV 
can be overestimated or underestimated depending on the 
biological response of the glioblastoma to treatment, and 
the resolution of this issue is limited by the currently 
available MRI technology. However, methionine positron 
emission tomography can help to confirm the presence 
of active tumor within the gadolinium- enhanced GTV, 
whereas diffusion- weighted MRI and multivoxel MR spec-
troscopy may detect nonenhancing tumor without 
hyperpermeable vasculature [19, 20]. Third, we did not 
account for infiltrative nonenhanced disease in the model 
because the purpose of this study is to address bulk changes 
in distribution of the TTFields and energy deposition by 
varying the physical aspects of the treatment delivery. Lastly, 
we only performed modeling on one patient. It will require 
comparison of multiple patients, in particular between 
responders and nonresponders, in order to determine the 
relevant parameters that influence TTFields in the glio-
blastoma population.
In conclusion, we constructed volume histograms EVH 
and SARVH to facilitate future comparisons between 
Figure 9. Electric field and rate of energy deposition results in the GTV geometric analysis. EVH was constructed according to the geometries 
displayed in Figure 8A and B (A). SARVH was constructed according to the geometries displayed in Figures 8A and B. Electric field and SAR results are 
listed for various GTV geometries (C). GTV, gross tumor volume; EVH, electric field–volume histogram; SARVH, specific absorption rate–volume 
histogram; EAUC, electric field area under the curve; VE150, volume covered with electric field intensity of 150 volts per meter; E95%, the electric field 
intensity encompassing 95% of volume; E50%, the electric field intensity encompassing 50% of volume; E20%, the electric field intensity encompassing 
20% of volume; SAR, specific absorption rate; SARAUC, SAR area under the curve; VSAR7.5, volume covered with specific absorption rate of 7.5 watts 
per kilogram; SAR95%, the magnitude of specific absorption rate encompassing 95% of volume; SAR50%, the magnitude of specific absorption rate 
encompassing 50% of volume; SAR20%, the magnitude of specific absorption rate encompassing 20% of volume.
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glioblastoma patients undergoing treatment with TTFields. 
TTFields at the GTV are influenced by the dielectric 
characteristics of the adjacent tissues as well as the GTV 
itself, particularly the presence or absence of a conductive 
necrotic core. The amount of cerebrospinal fluid at the 
convexity of the brain and the geometry of the tumor 
are additional relevant factors. Finally, the position of 
the arrays also can influence the electric field distribution 
and rate of energy deposition within the GTV.
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